about
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryImmunologic response to highly active antiretroviral therapy and mortality reduction in a cohort of human immunodeficiency virus-positive persons in Mozambique.Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network.Nutritional rehabilitation of HIV-exposed infants in Malawi: results from the drug resources enhancement against AIDS and malnutrition programAn assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.Assessment of frailty in community-dwelling older adults residents in the Lazio region (Italy): A model to plan regional community-based services.Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibilityCMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding.Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants.Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life.Weight changes during and after 6 months of breastfeeding in HIV-infected mothers receiving antiretroviral therapy in Malawi.Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique.Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the Drug Resource Enhancement Against AIDS and Malnutrition model: antiretrovirals for 5 reduction of population infectivity, incidence and prevalence at the district levelDeterminants of acute hospital care use by elderly patients in Italy from 1996 to 2006.Laboratory confirmation of clinically diagnosed malaria in a cohort of HIV-infected mothers and their children in Malawi.The DREAM model's effectiveness in health promotion of AIDS patients in Africa.Social Interventions to Prevent Heat-Related Mortality in the Older Adult in Rome, Italy: A Quasi-Experimental Study.Correction: Reduction of Maternal Mortality with Highly Active Antiretroviral Therapy in a Large Cohort of HIV-Infected Pregnant Women in Malawi and MozambiqueAnalysis of survival in a sample of elderly patients from Ragusa, Italy on the basis of a primary care level multidimensional evaluation
P50
Q26778483-8DF13793-AB5D-4CB0-9F8B-3C8C1E42ED18Q28534751-95230E46-9893-479B-87B1-AD1EEC4D36B7Q34240160-DC9C7FC5-B493-4371-B9F8-36865ACD6C9BQ34266269-70A95A61-B7EB-4AF8-B5C0-E77991B72E46Q35860439-8A96C5C3-E51D-4FF0-B4C0-291075E1CDDCQ36888760-89A1E73C-D71A-4F90-9E82-81AA8FDBED3FQ37889592-466475EF-082D-4F13-BE30-1A7DB7F3F58CQ38452483-4C7F4420-26BD-41AF-AA09-20846EBC203CQ38966133-7FC54204-F7E9-48FE-937A-2ABB63459AC2Q39213753-9D70D848-A1D7-4F35-AC37-9F809A7552CAQ39213760-C440E82C-8E0D-4AEF-A894-BA4FDE0BADE8Q39447619-89788027-D160-4877-A717-B54A1D252B1BQ39520236-4C101234-86F6-41F1-B5F5-46E8AD27AD2BQ39555733-9343C9EA-9081-466D-8615-46203794E88FQ40540194-B537CC0F-EBF9-452E-A8D8-FC20A1064D87Q40719420-86A6FE45-2F01-42D3-85D6-32485FBEDB0EQ40833730-CF14E517-7BFB-47D4-8F85-C32405CE4DA7Q40962161-9035DD74-0C01-44FE-A28F-BD36A15511F5Q41760045-495E7385-36E9-4B70-A089-30C906A3322BQ42872394-258AEB35-1D65-49AF-B402-766A2867389EQ43049052-501F37EE-258F-4916-8032-C3898F5D2006Q44237932-8D64644A-2854-4401-89CA-D95BF7AD4E8EQ44799271-51925D96-C7E2-425B-81D0-671E66D37260Q45965102-9BE8E8F4-67DA-4CFB-B3AB-6B76EDA753C5Q46142443-B6802AF7-D22F-4571-AC7D-0739DB9A48ACQ53117150-996345BE-54F3-4605-8366-D009AB5C1F4EQ55361384-A38C65F0-29CE-450D-BC6A-0CBAF0456191Q57951537-14BF3179-336B-4BEE-9CD1-632350837E97Q57951633-36DAB7F0-96CC-4147-B490-DC1D944EB001
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paola Scarcella
@ast
Paola Scarcella
@en
Paola Scarcella
@es
Paola Scarcella
@nl
type
label
Paola Scarcella
@ast
Paola Scarcella
@en
Paola Scarcella
@es
Paola Scarcella
@nl
prefLabel
Paola Scarcella
@ast
Paola Scarcella
@en
Paola Scarcella
@es
Paola Scarcella
@nl
P106
P1153
56902973500
6508157381
P21
P31
P496
0000-0002-3319-7925